Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael Z Liao
Michael Z Liao
Amgen
Medicine
Panitumumab
Internal medicine
Oncology
Dosing
3
Papers
9
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The PSMA Targeting Half-Life Extended BiTE® Therapy AMG 160 Has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-Resistant Prostate Cancer.
2021
Clinical Cancer Research
Petra Deegen
Oliver Thomas
Olivier Nolan-Stevaux
Shyun Li
Joachim Wahl
Pamela Bogner
Famke Aeffner
Matthias Friedrich
Michael Z Liao
Katja Matthes
Doris Rau
Benno Rattel
Tobias Raum
Peter Kufer
Angela Coxon
Julie M. Bailis
Show All
Source
Cite
Save
Citations (8)
The impact of hepatic and renal function on panitumumab exposures in patients with metastatic RAS wild-type colorectal cancer.
2021
Cancer Chemotherapy and Pharmacology
Michael Z Liao
Hans Prenen
Sandeep Dutta
Vijay V. Upreti
Show All
Source
Cite
Save
Citations (0)
Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Response to Letter]
2020
Michael Z Liao
Johannes Kast
Marloes Berkhout
Hans Prenen
Sandeep Dutta
Vijay V. Upreti
Show All
Source
Cite
Save
Citations (1)
1